BOONTON, N.J., May 21, 2012 /PRNewswire/ -- Unigene Laboratories, Inc.

The U.S.

Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many.

BASKING RIDGE, N.J., March 28, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced

BASKING RIDGE, N.J., March 14, 2012 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced